vellena 75+30 mikrogram overtrukne tabletter
actavis group ptc ehf. - ethinylestradiol, gestoden - overtrukne tabletter - 75+30 mikrogram
denise 150+30 mikrogram tabletter
2care4 aps - desogestrel, ethinylestradiol - tabletter - 150+30 mikrogram
alunbrig
takeda pharma a/s - brigatinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.
lorviqua
pfizer europe ma eeig - lorlatinib - carcinom, ikke-småcellet lunge - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.
natriumoxybat "ascend" 500 mg/ml oral opløsning
ascend gmbh - natriumoxybat - oral opløsning - 500 mg/ml
natriumoxybat "kalceks" 500 mg/ml oral opløsning
kalceks as - natriumoxybat - oral opløsning - 500 mg/ml
natriumoxybat "reig jofre" 500 mg/ml oral opløsning
laboratorio reig jofre s.a. - natriumoxybat - oral opløsning - 500 mg/ml
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - andre narkotika stoffer - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
levonorgestrel/ethinylestradiol "2care4" 0,10+0,02 mg filmovertrukne tabletter
2care4 aps - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 0,10+0,02 mg